Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP–NF-κB interaction in activated microglia

By Delgado M.  

Biochemical and Biophysical Research Communications, Vol. 297, Iss. 5, 2002-10 ,pp. : 1181-1185

Elsevier

Access to resources Recommend Favorite

The Inhibitory Effects of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide on Osteoclast Formation Are Associated with Upregulation of Osteoprotegerin and Downregulation of RANKL and RANK

By Mukohyama H.   Ransjö M.   Taniguchi H.   Ohyama T.   Lerner U.H.  

Biochemical and Biophysical Research Communications, Vol. 271, Iss. 1, 2000-04 ,pp. : 158-163

Elsevier

Access to resources Recommend Favorite

The Human Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase Activating Peptide Receptor 1 (VPAC1): Constitutive Activation by Mutations at Threonine 343

By Gaudin P.   Couvineau A.   Rouyer-Fessard C.   Maoret J-J.   Laburthe M.  

Biochemical and Biophysical Research Communications, Vol. 254, Iss. 1, 1999-01 ,pp. : 15-20

Elsevier

Access to resources Recommend Favorite

Heterologous Upregulation of Nerve Growth Factor-TrkA Receptors in PC12 Cells by Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)

By Lazarovici P.   Fink D.  

Molecular Cell Biology Research Communications, Vol. 2, Iss. 2, 1999-08 ,pp. : 97-102

Academic Press

Access to resources Recommend Favorite

Pituitary Adenylate Cyclase-Activating Polypeptide Prevents Cytokine-Induced Cytotoxicity via Inhibition of Inducible Nitric Oxide Synthase Expression in βTC Cells

By Sekiya K.   Nagasaki H.   Ozaki N.   Suzuki A.   Miura Y.   Oiso Y.  

Biochemical and Biophysical Research Communications, Vol. 278, Iss. 1, 2000-11 ,pp. : 211-216

Elsevier

Access to resources Recommend Favorite